163 related articles for article (PubMed ID: 34522245)
1. Downregulation of long non-coding RNA B-Raf proto-oncogene-activated non-coding RNA reverses cisplatin resistance in laryngeal squamous cell carcinoma.
Han W; Niu L; Wang L; Liu J; Li H
Arch Med Sci; 2021; 17(5):1164-1174. PubMed ID: 34522245
[TBL] [Abstract][Full Text] [Related]
2. The implication of LncRNA MALAT1 in promoting chemo-resistance of laryngeal squamous cell carcinoma cells.
Jiang Q; Liu S; Hou L; Guan Y; Yang S; Luo Z
J Clin Lab Anal; 2020 Apr; 34(4):e23116. PubMed ID: 31837057
[TBL] [Abstract][Full Text] [Related]
3. [Procyanidins enhance the chemotherapeutic sensitivity of laryngeal carcinoma cells to cisplatin through autophagy pathway].
Yu F; Liu W; Gong XR; Zhou YB; Lin Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Mar; 32(6):447-456. PubMed ID: 29737742
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of c-fos in resistant cell line TU177/VCR of larynx squamous cell carcinoma].
Li GD; Hu XL; Xing JF; Shi RY; Li X; Li JF; Li TL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):281-285. PubMed ID: 29747253
[No Abstract] [Full Text] [Related]
6. [Effects of serine/threonine-protein kinase B-Raf-activated long-chain non-coding RNA on apoptosis and autophagy in thyroid carcinoma cells].
Liu T; Zhao Y; Wang L; Jia H; Cui D; Si Y; Wang H; Xue H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):747-753. PubMed ID: 30124210
[TBL] [Abstract][Full Text] [Related]
7. lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis.
Liang ZY; Zhang ZM; Sun GR; Zhao BS; Xin GH; Zhang L
Am J Cancer Res; 2023; 13(6):2732-2750. PubMed ID: 37424811
[TBL] [Abstract][Full Text] [Related]
8. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA BANCR promotes proliferation and migration in oral squamous cell carcinoma via MAPK signaling pathway.
Yao C; Kong F; Zhang S; Wang G; She P; Zhang Q
J Oral Pathol Med; 2021 Mar; 50(3):308-315. PubMed ID: 31654433
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
12. LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway.
Miao X; Liu Y; Fan Y; Wang G; Zhu H
Cancer Manag Res; 2021; 13():287-296. PubMed ID: 33469371
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
Yu X; Huang M; Yang G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
[TBL] [Abstract][Full Text] [Related]
14. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
15. Myeloid differentiation factor 88 promotes cisplatin chemoresistance in ovarian cancer.
Liu G; Du P; Zhang Z
Cell Biochem Biophys; 2015 Mar; 71(2):963-9. PubMed ID: 25308861
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
17. [Long non-coding RNA XIST modulates cisplatin resistance by altering PDCD4 and Fas-Lexpressions in human nasopharyngeal carcinoma HNE1 cells
Wang H; Li W; Tan G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):357-363. PubMed ID: 31068307
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MIAT promotes the proliferation and invasion of laryngeal squamous cell carcinoma cells by sponging microRNA-613.
Song F; Yang Y; Liu J
Exp Ther Med; 2021 Mar; 21(3):232. PubMed ID: 33603840
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA terminal differentiation-induced non-coding RNA regulates cisplatin resistance of choroidal melanoma by positively modulating extracellular signal-regulated kinase 2 via sponging microRNA-19b-3p.
Li W; Nie A; Jin L; Cui Y; Xie N; Liang G
Bioengineered; 2022 Feb; 13(2):3422-3433. PubMed ID: 35067169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
